The first consensus conference definition of CTE-NC included neuronal p-tau in the CA2 region of the hippocampus, hypothalamus, thalamus, and amygdala and defined that pathology as “supportive features” of CTE-NC (1). The gene discussed is MAPT; the disease is nevus comedonicus syndrome.